TCI Co., Ltd. (8436) 2025 Q3 Investor Conference

Company Overview

TCI Co., Ltd. (8436) is a biotech company with a global presence, aiming to become the No.1 leading biotech company. The company's purpose is Longevity with Joy and Wellness, and its mission is to join and delight consumers' lives. TCI has a strong global layout with 7 locations, 4 smart manufacturing centers, and 67 sales regions.

Financial Highlights

The company's financial highlights for 2025 H1 include:

• Revenue: NT$3,383,190, down 3.0% YoY
• Gross Profit: NT$1,440,678, down 3.6% YoY
• Operating Expenses: NT$959,284, down 12.4% YoY
• Operating Income: NT$481,394, up 20.5% YoY
• Net Income Attributable to Owners of Parent: NT$374,642
• EPS: NT$3.39

Business Segments

TCI has a diversified business with multiple products and technologies, including:

• GLP1-Formula
• ZeroO2
• SUGAR LOCK 花生膜前花青素
• Feel Pro Metabolic
• Wellosophy Metabo Boost
• Snep Choco Block
• Nutrition29 DietVita GLP slim
• Wa Slim® 短雙歧桿菌複合飲品
• Wellosophy 瑞爾姿 紅茶馬齒莧壓片糖果
• Unique Time大豆紅茶發酵菌粉飲料

Products & Technologies

The company has developed various products and technologies, including:

• TCI250
• TCI 378 益生菌
• TCI 507 益生菌
• TCI 153
• TCI 633
• 白玉石榴萃取 *香蕉皮
• 咖啡櫻桃
• 石榴酵素
• 花生膜 *香蕉花
• 黃精
• 蕎麥種皮
• 山葵葉
• 海葡萄
• 青棗幼果
• 高良月桃
• 紅藜
• 芭樂幼果
• 紅龍果胚珠
• 重瓣玫瑰
• 黑番茄

Clients & Markets

TCI has a strong global customer base with 1400+ customers and 17 key accounts. The company's revenue distribution by region is:

• CN: 26%
• AS: 31%
• US: 30%
• EU: 13%

ESG / Sustainability

TCI is committed to sustainability and has obtained various international certifications, including:

• RE100
• EP100
• SBTi
• AWS
• CDP Climate Change Questionnaire B-level rating
• S&P Global Corporate Sustainability Assessment Top 15% in industry
• EcoVadis Silver Medal

Outlook & Strategy

The company's future outlook and guidance include:

• Expanding its global presence through asset-light expansion
• Developing new products and technologies
• Enhancing its sustainability and ESG practices

Additional Data

Additional data and charts are available, including:

• Regional revenue distribution chart
• R&D achievements
• Interstitial fluid glucose chart
• GLP1 formula product order amount chart
• ZeroO2 monthly demand chart
• Financial tables (income statement, balance sheet, and cash flow statement)